Articles by Nipon Das, MD - BioPharm International

ADVERTISEMENT

ADVERTISEMENT

Articles by Nipon Das, MD

Final Word: Creative Solutions Can Ensure Pandemic Flu Preparedness

Public-private business models can reduce the risk of investing in vaccine manufacturing
May 1, 2006

Certain areas of the vaccine market appear to be in vogue again, revitalized by blockbusters such as Prevnar, the pneumococcal pneumonia vaccine that reaped $1.5 billion in sales last year, and the human papilloma virus vaccines, which are projected to reach $4 billion per year.

ADVERTISEMENT

ADVERTISEMENT

Click here